Category Archives: IAS 2019

IAS 2019: Collapse of Venezuela’s health infrastructure dismantles HIV response

By on .

MEXICO CITY – A decade ago, Venezuela had one of the most progressive responses to its HIV epidemic in the world. In the 1990s the country’s Supreme Court mandated that the government provide lifesaving antiretroviral therapy, catalyzing a national HIV program which provided comprehensive care to everyone who qualified. Now, after more than five years […]

IAS 2019: Scientist highlights the weight of the smallest organism in HIV risk

By on .

MEXICO CITY – When you think of factors associated with increased risks of acquiring HIV, big pictures of marginalization, discrimination, geographic location, economic inequities and gender inequality might come to mind. With two maps here on Tuesday, a scientist zeroed in on a factor that, while literally microscopic, can also make a great difference: bacteria. On […]

IAS 2019: While plans for HIV control innovations accelerate, community input remains an afterthought

By on .

MEXICO CITY – “What HIV has pointed out is that building it does not make them come,” Ambassador Dr. Deborah Birx noted at an opening night press event that highlighted persisting gaps in HIV testing, treatment, prevention access across the globe. When services don’t reach clients and communities, she said, people offering them have to […]

IAS 2019: While dispelling concerns of DPM HIV risk, ECHO study yields data on STIs, PrEP interest, pregnancy rates

By on .

MEXICO CITY – Women using Depo Provera as a long acting, injectable hormonal contraceptive showed lower rates of sexually transmitted infection that include chlamydia and gonorrhea, during a study undertook with the primary aim of assessing whether the drug raised risks of HIV infection. This is one in several findings released Monday from the Evaluation of […]

IAS 2019: Data shows indigenous, nonbinary populations among those missed by HIV epidemic ending efforts

By on .

MEXICO CITY – Indigenous communities in the Americas are largely being left out of efforts to achieve UNAIDS’ global HIV elimination targets of 90 percent of people knowing their HIV status by 2020, 90 percent of people diagnosed with HIV accessing lifesaving antiretroviral therapy, and 90 percent of people on treatment achieving viral suppression, indigenous leaders […]

IAS 2019: With new data, WHO updates DTG guidelines including women in strong, preferred recommendation

By on .

MEXICO CITY – Responding to expanded data gathered in Botswana and Brazil, and to input from communities of women living with HIV, the World Health Organization announced updated guidelines for the use of dolutegravir, restoring the agency’s recommendation that the antiretroviral medicine with fewer side effects, lower resistance, and quicker viral suppression than alternatives is […]

IAS 2019: Recency testing opens doors to faster, focused HIV responses, raises questions of community involvement

By on .

MEXICO CITY – On Sunday here in a preconference session, U.S. PEPFAR leader Ambassador Dr. Deborah Birx extolled the value of HIV recency tests – a diagnostic advance that can tell if a person newly diagnosed with HIV was infected in the last year, or before. That information can help identify new clusters of transmissions, […]

IAS 2019: Preventing TB — the leading killer of people with HIV — remains tangential to global HIV responses

By on .

MEXICO CITY – In a day-long, pre-conference meeting devoted to addressing tuberculosis prevention among people living with HIV, which continues to account for one in three HIV-related deaths globally, experts discussed the urgent need to listen to communities about their TB prevention needs and offer people-centered interventions. This includes integrating TB prevention services at family planning […]